Pomerantz LLP is investigating claims on behalf of investors of  Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO).  Such investors are advised to contact Danielle Peyton ...

COPENHAGEN (Reuters) -Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts warned of persistent ...

Novo Nordisk › The hits just kept coming for beleaguered Ozempic and Wegovy maker Novo Nordisk (NYSE: NVO) on Thursday. The company, which has been slammed with investor sell-offs since cutting its ...

Good morning. Apple’s third-quarter revenue crushes estimates. Eli Lilly lets down investors after a head-to-head drug trial.

Plus: Trump to announce new tariffs as Australia braces for 15% rate; Microsoft hits US$4 trillion as AI momentum builds; ...

Shares of telehealth company Hims & Hers Health are up Thursday afternoon. The rally comes amid significant headwinds for major pharmaceutical companies in the lucrative weight-loss drug market.

Stock futures climbed on Thursday (July 31) after strong quarterly results from tech heavyweights Microsoft and Meta ...

A rally in stocks sputtered ahead of President Donald Trump’s tariff deadline, with the White House demanding drugmakers to ...

Novo Nordisk (NVO) downgraded to Hold by HSBC amid growth concerns, GLP-1 market challenges, and revised 2025-2026 earnings ...

July's jobs report reveals mixed signals. Discover key sectors with growth momentum and risks in labor trends to ...

A rally in stocks fizzled out ahead of President Donald Trump’s tariff deadline, with the White House demanding drugmakers to ...

Yesterday, we reported that Novo Nordisk (NYSE: NVO) stock crashed over 20% in premarket trading yesterday. The main culprit is the reduced sales forecast for the company’s flagship obesity drug ...